Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Red Cell Partners is an active venture creation firm that builds, launches, and scales technology-led companies in healthcare, cyber, and national security. It has launched or created over 14–19 companies since its founding in 2020. Its model involves deep operational involvement from inception through early growth stages. In healthcare/life sciences specifically, it has incubated Zephyr AI (precision medicine/AI), among others. Clinical results are reported at the portfolio company level rather than at the parent level.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Red Cell Partners.